JP2023552383A5 - - Google Patents
Info
- Publication number
- JP2023552383A5 JP2023552383A5 JP2023533889A JP2023533889A JP2023552383A5 JP 2023552383 A5 JP2023552383 A5 JP 2023552383A5 JP 2023533889 A JP2023533889 A JP 2023533889A JP 2023533889 A JP2023533889 A JP 2023533889A JP 2023552383 A5 JP2023552383 A5 JP 2023552383A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- pharmaceutical composition
- terminus
- cancer
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063121762P | 2020-12-04 | 2020-12-04 | |
| US63/121,762 | 2020-12-04 | ||
| PCT/US2021/061886 WO2022120226A1 (en) | 2020-12-04 | 2021-12-03 | Peptide receptor radionuclide therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552383A JP2023552383A (ja) | 2023-12-15 |
| JP2023552383A5 true JP2023552383A5 (cg-RX-API-DMAC7.html) | 2024-12-05 |
Family
ID=81853616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023533889A Pending JP2023552383A (ja) | 2020-12-04 | 2021-12-03 | ペプチド受容体放射性核種療法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12649008B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4255891A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023552383A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230117581A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116829541A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021390552A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3203175A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023006483A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022120226A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2025211123A1 (en) | 2024-01-26 | 2026-08-13 | The Regents Of The University Of California | Peptide receptor radionuclide therapy |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO881077L (no) * | 1987-03-11 | 1988-09-12 | Univ Michigan | Kjemo-radio-immuno-konjugater. |
| AU2008230771B2 (en) * | 2007-03-27 | 2014-05-08 | Radiomedix Inc. | Compositions for targeted imaging and therapy |
| WO2010047839A1 (en) * | 2008-10-25 | 2010-04-29 | Aura Biosciences | Modified plant virus particles and uses therefor |
| WO2011082191A1 (en) * | 2009-12-30 | 2011-07-07 | Ge Healthcare Limited | Method of using a 99mtc-labelled injection rgd compound and a [18f]-labelled rgd injection compound in external beam radiotherapy planning |
| WO2015160770A1 (en) | 2014-04-15 | 2015-10-22 | The Regents Of The University Of California | Bi-terminal pegylated integrin-binding peptides and methods of use thereof |
| CN109563135B (zh) | 2016-06-13 | 2024-01-23 | 加利福尼亚大学董事会 | α(V)β(6)整合素结合肽及其使用方法 |
| CN109982998A (zh) | 2016-11-23 | 2019-07-05 | 癌靶技术有限责任公司 | 白蛋白结合psma抑制剂 |
| GB201706472D0 (en) * | 2017-04-24 | 2017-06-07 | Cancer Res Tech Ltd | Tumour-targeting peptide variants |
| US11478558B2 (en) * | 2017-05-30 | 2022-10-25 | The Johns Hopkins University | Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer |
| CN109091683B (zh) * | 2018-08-10 | 2019-10-18 | 北京大学 | 一种用于整合素αvβ6靶向的环状多肽放射性药物及其制备方法 |
| EP3846858A4 (en) | 2018-09-07 | 2022-10-19 | The Regents of the University of California | ALPHA-(V)BETA(6)INTEGRIN-BINDING PEPTIDES AND METHODS OF USE THEREOF |
| WO2021226432A2 (en) | 2020-05-08 | 2021-11-11 | The Regents Of The University Of California | Methods of detecting and treating lung damage in respiratory-related viral infections |
-
2021
- 2021-12-03 CN CN202180092891.6A patent/CN116829541A/zh active Pending
- 2021-12-03 WO PCT/US2021/061886 patent/WO2022120226A1/en not_active Ceased
- 2021-12-03 MX MX2023006483A patent/MX2023006483A/es unknown
- 2021-12-03 CA CA3203175A patent/CA3203175A1/en active Pending
- 2021-12-03 EP EP21901568.2A patent/EP4255891A4/en active Pending
- 2021-12-03 JP JP2023533889A patent/JP2023552383A/ja active Pending
- 2021-12-03 KR KR1020237020941A patent/KR20230117581A/ko active Pending
- 2021-12-03 US US18/038,851 patent/US12649008B2/en active Active
- 2021-12-03 AU AU2021390552A patent/AU2021390552A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3766893B1 (en) | 177lu-dota-hynic-ipsma as a therapeutic radiopharmaceutical targeting prostate-specific membrane antigen | |
| Rosar et al. | New horizons in radioligand therapy: 161Tb-PSMA-617 in advanced mCRPC | |
| Hu et al. | Efficacy and safety of stereotactic body radiotherapy combined with camrelizumab and apatinib in patients with hepatocellular carcinoma with portal vein tumor thrombus | |
| CN111629755A (zh) | 联合放射疗法治疗癌症的粒子 | |
| JP7447300B2 (ja) | 放射性金属と複合するDZ-1-Lys-DOTAコンジュゲート及び使用 | |
| US6391911B1 (en) | Coadministration of lucanthone and radiation for treatment of cancer | |
| JP2023547689A5 (cg-RX-API-DMAC7.html) | ||
| EA020542B1 (ru) | Альфа-излучающие частицы гидроксиапатита | |
| WO2019094053A1 (en) | Disulfiram and copper salt dosing regimen | |
| Janssen et al. | Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: effect of the radionuclide | |
| Chen et al. | In vivo examination of 188Re (I)-tricarbonyl-labeled trastuzumab to target HER2-overexpressing breast cancer | |
| Zulkowski et al. | Regression of brain metastases from breast carcinoma after chemotherapy with bendamustine | |
| Sano et al. | In vivo evaluation of a radiogallium-labeled bifunctional radiopharmaceutical, Ga-DOTA-MN2, for hypoxic tumor imaging | |
| Wagman et al. | Adjuvant therapy for pancreatic cancer: current treatment approaches and future challenges | |
| Riva et al. | Radioimmunotherapy of gastrointestinal cancer and glioblastomas | |
| CN118302202A (zh) | 用于治疗癌症的化合物及其组合物 | |
| Jeekel | Adjuvant or neoadjuvant therapy for pancreatic carcinoma? | |
| Yin et al. | A novel CXCR4-targeted peptide for SPECT/CT imaging in tumor | |
| KR20230117581A (ko) | 펩티드 수용체 방사성 핵종 요법 | |
| CN118267494B (zh) | 一种镭-224标记的金属有机框架纳米药物及其制备方法与应用 | |
| Sartor et al. | Stromal targeted therapy in bone metastatic prostate cancer: promise delivered | |
| Prieto | European Association of Nuclear Medicine–35th Annual Congress. Barcelona–October 15-19, 2022 | |
| Behera et al. | Ifosfamide containing regimen for non-small cell lung cancer | |
| JP2025502955A (ja) | 抗体内包金属フラーレン複合体及びその使用 | |
| Sun et al. | Small cell carcinoma of the Hypopharynx |